PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.14%
Revenue growth above 1.5x MRVL's 4.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.66%
Gross profit growth above 1.5x MRVL's 3.82%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
17.15%
EBIT growth above 1.5x MRVL's 8.09%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
17.15%
Operating income growth similar to MRVL's 15.99%. Walter Schloss would assume both share comparable operational structures.
20.87%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
20.00%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.00%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.82%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.33%
Diluted share count expanding well above MRVL's 1.17%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.82%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
68.24%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
830.00%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
110.16%
10Y revenue/share CAGR above 1.5x MRVL's 56.20%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
77.19%
5Y revenue/share CAGR at 50-75% of MRVL's 109.65%. Martin Whitman would worry about a lagging mid-term growth trajectory.
45.91%
3Y revenue/share CAGR above 1.5x MRVL's 25.49%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
164.73%
5Y OCF/share CAGR above 1.5x MRVL's 45.44%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
147.97%
3Y OCF/share CAGR above 1.5x MRVL's 63.72%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1724.99%
Net income/share CAGR above 1.5x MRVL's 653.69% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2101.73%
5Y net income/share CAGR above 1.5x MRVL's 220.76%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
224.85%
3Y net income/share CAGR 1.25-1.5x MRVL's 202.86%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
25.90%
5Y equity/share CAGR 1.25-1.5x MRVL's 19.67%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
53.12%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
47.43%
10Y dividend/share CAGR above 1.5x MRVL's 0.04%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
-16.51%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-22.60%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
16.65%
AR growth well above MRVL's 11.24%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.20%
Inventory growth well above MRVL's 4.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.28%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.82%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
0.24%
Debt shrinking faster vs. MRVL's 3.89%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
0.94%
R&D growth drastically higher vs. MRVL's 1.74%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
17.41%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.